While INFO tells you about your Excel environment, CELL digs into individual cells and returns details about their formatting ...

Once you’ve built a Pivot Table, turning it into a chart is almost too easy. Simply click anywhere inside the table, go to Insert > PivotChart, and select your preferred chart type. You’d even get a ...

In tissue biopsies, cancer cells are frequently observed to have nuclei (the cell's genetic information storage) that are larger than normal. Until now, this was considered a sign that the cancer was ...

Our bodies are made up of countless cells, and each one is enclosed by a thin layer called the cell membrane. This membrane is not a rigid wall, but a soft, flexible sheet made of lipids. Beneath it ...

When cells are healthy, we don't expect them to suddenly change cell types. A skin cell on your hand won't naturally morph into a brain cell, and vice versa. That's thanks to epigenetic memory, which ...

Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non–Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B) Patients with unresected ...

In a new study, researchers from the University of Chicago discovered that zeaxanthin, a plant-derived carotenoid best known for protecting vision, may also act as an immune-boosting compound by ...

Another cell therapy biotech has run out of steam, this time before ever reaching the clinic. California CAR-T company Appia Bio has closed up shop, founding CEO JeenJoo “JJ” Kang, Ph.D., wrote in an ...

HUNTSVILLE, Ala. (WAFF) - A man on death row for Huntsville’s notorious ‘cell phone murders’ has lost another appeal. On Friday, Alabama’s Court of Criminal Appeals rejected Joey Wilson’s application ...

Shineco Inc. (NASDAQ:SISI) shares are trading higher on Wednesday after the company announced the launch of what it calls the world's first on-chain cell asset tokenization platform. See what is ...

A Pfizer drug designed to address a severe problem associated with sickle cell disease failed to beat a placebo in a Phase 3 clinical trial. It’s the latest setback for Pfizer in this inherited blood ...